Dividend Kings for 2024 - Part II

Are these worth buying?

Dividend Download

Top dividend stocks & news

Royal Returns: The 14 Best Dividend Kings for 2024 - Part II

Welcome to part 2 of our exploration into the top Dividend Kings of 2024. You can check part I here.

Let’s pick up where we left off and explore the next batch of Dividend Kings that are shaping the future of steady, long-term income.

8. National Fuel Gas (NFG)

Why Invest: National Fuel Gas benefits from its diversified business model, which includes utility operations and exploration and production of natural gas. Its P/E ratio of 14.3 is reasonable for the energy sector, suggesting that the stock is priced fairly. The company’s cash flow is robust, exceeding $600 million annually, which supports its 3.39% dividend yield. Its expansion into renewable energy could position the company for growth as the energy landscape shifts.

Why Not Invest: National Fuel Gas is vulnerable to fluctuations in natural gas prices, which could impact revenue and cash flow. Additionally, as the energy sector faces increasing pressure to transition to renewable energy, National Fuel Gas’s reliance on fossil fuels could expose it to regulatory and market risks. High debt levels in the energy sector could become problematic in a rising interest rate environment, impacting profitability.

Verdict: 

9. Kimberly-Clark (KMB)

Why Invest: Kimberly-Clark’s portfolio of essential products, including tissue paper and diapers, ensures steady demand, regardless of economic conditions. The company has a solid cash flow of over $3 billion annually and a relatively low P/E ratio of 18.5, indicating that the stock is fairly valued for its stability. Kimberly-Clark’s dividend yield of 3.36% is supported by strong and consistent revenue, with a growing presence in emerging markets contributing to long-term growth.

Why Not Invest: Kimberly-Clark faces rising raw material costs, particularly in the pulp and paper sectors, which could pressure margins. Intense competition in the consumer goods sector, along with price sensitivity among consumers, could limit the company's ability to pass on these costs. The company’s limited growth opportunities in mature markets could make it harder to increase revenue significantly in the future.

Verdict: 

10. Consolidated Edison (ED)

Why Invest: Consolidated Edison operates in a stable, regulated utility sector, providing reliable income with a dividend yield of 3.15%. The company has a solid cash flow from its electric, gas, and steam operations in the New York City area. Its P/E ratio of 18.1 is typical for utility companies, reflecting its stable earnings. Consolidated Edison’s investments in clean energy could support long-term growth as the market transitions to renewable energy.

Why Not Invest: Consolidated Edison has high operating costs due to its urban service area, which can reduce profitability. The company is also highly indebted, with a significant amount of debt to fund infrastructure projects. Rising interest rates could increase borrowing costs, putting pressure on its financials. Like many utilities, Consolidated Edison’s growth prospects are limited, and any regulatory changes or environmental concerns could affect future earnings.

Verdict: 

PepsiCo (PEP)

  • Why Invest: PepsiCo, with a market capitalization of $241.2 billion, has demonstrated impressive cash flow and strong brand recognition across its diverse portfolio, including brands like Pepsi, Gatorade, and Tropicana. The company continues to expand through strategic acquisitions and innovations, particularly in the healthier snack and beverage sectors, which positions it well for future growth. PepsiCo boasts a solid dividend track record with 52 consecutive years of increases, and its P/E ratio of 24.5 reflects strong investor confidence. PepsiCo's global presence ensures a steady revenue stream from both developed and emerging markets, further supported by stable cash flow from its snack food segment.

  • Why Not Invest: While PepsiCo's dividend yield of 3.08% is attractive, the stock's P/E ratio is relatively high compared to its industry peers, signaling that it may be somewhat overvalued. Additionally, the company faces increased competition in both the beverage and snack sectors, and its dependence on international markets exposes it to currency fluctuations and geopolitical risks. Furthermore, PepsiCo’s profitability could be pressured by rising input costs, especially with raw materials and transportation expenses.

Verdict: 

Stanley Black & Decker (SWK)

  • Why Invest: Stanley Black & Decker, with a market cap of $16.5 billion, has long been a leader in the tools and hardware industry. The company continues to benefit from strong brand recognition, especially in power tools, and has a diversified product line across multiple industries, including industrial and home improvement markets. Stanley Black & Decker is well-positioned for long-term growth, with innovative products and a solid dividend history of 57 years. Its current dividend yield of 3.06% and consistent cash flow indicate the company's ability to continue rewarding shareholders.

  • Why Not Invest: Stanley Black & Decker faces potential risks from an economic downturn, as its products are closely tied to the health of the housing and construction markets. Its P/E ratio of 18.9, while not excessively high, suggests some market optimism that may not be justified if consumer demand weakens. The company also carries a significant amount of debt, which could become problematic if interest rates rise or if the company faces any disruption in supply chains.

Verdict: 

Johnson & Johnson (JNJ)

  • Why Invest: Johnson & Johnson, a healthcare giant with a market cap of $394.4 billion, is a highly attractive dividend stock with a 62-year history of annual dividend increases. The company boasts a diversified revenue base, with operations spanning pharmaceuticals, medical devices, and consumer health products. JNJ has consistently strong cash flow and boasts a solid pipeline of products, including high-margin drugs like Stelara and Imbruvica. Its focus on innovation, along with its defensive nature in the healthcare space, makes it a reliable investment for income-seeking investors.

  • Why Not Invest: While Johnson & Johnson has an impressive dividend track record and strong fundamentals, its P/E ratio of 15.2 is slightly lower than some other dividend payers, indicating that growth potential may be limited in the near term. Additionally, ongoing litigation related to talc-based products and the opioid crisis could weigh on the company’s reputation and profitability. Johnson & Johnson's customer base is also somewhat dependent on the cyclical nature of healthcare spending, which could be negatively impacted by changes in government policies or healthcare reforms.

Verdict: 

Target (TGT)

  • Why Invest: Target has a strong market presence with a diversified retail business, offering everything from groceries to clothing and home goods. With a market cap of $73.9 billion and 57 years of consecutive dividend increases, it is a dependable dividend stock with a yield of 2.79%. Target has consistently delivered strong same-store sales growth, driven by its focus on e-commerce, private-label products, and in-store experiences. The company’s ability to adapt to changing consumer preferences positions it well for future growth, supported by strong cash flow and a solid balance sheet.

  • Why Not Invest: Target’s dividend yield of 2.79% is lower compared to other Dividend Kings, which may make it less attractive for income-focused investors. Additionally, Target operates in a highly competitive retail market, with increasing pressure from e-commerce giants like Amazon. The company’s exposure to supply chain issues and rising labor costs may negatively affect margins. Target’s relatively high P/E ratio of 21.4 suggests that the stock may be overvalued in the current market, which could limit short-term growth potential.

Verdict: 

Resources

👩🏽‍⚖️ Legal Stuff
Nothing in this newsletter is financial advice. Always do your own research and think for yourself.